Tag - GBM

Developments

DelMar Pharma enrolls first patient in adjuvant arm of Phase 2 glioblastoma trial

DelMar Pharmaceuticals (NASDAQ:DMPI) treated the first MGMT-unmethylated glioblastoma multiforme (GBM) patient in the adjuvant trial arm of its Phase 2 study of VAL-083. This study arm will enroll up to 24 newly...

July 24, 2019

Feature

Diffusion Pharma readies pivotal hypoxic GBM trial

By Len Zehr Diffusion Pharmaceuticals (NASDAQ:DFFN) expects to begin before the end of 2017 a pivotal clinical trial with its trans sodium crocetinate (TSC) lead compound to re-oxygenate oxygen-deprived tissue in...

October 3, 2017

Tag - GBM

DelMar Pharma enrolls first patient in adjuvant arm of Phase 2 glioblastoma trial

Diffusion Pharma readies pivotal hypoxic GBM trial

General

More